← back to search

Маниге Кониг

Eli Lilly (United States) · US
Area of research
Endocrinology, Diabetes and Metabolism · Molecular Biology
Research interest
Research interests include Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Bariatric Surgery and Outcomes, and Diabetes Management and Research.
h-index
16
citations
1,279
works
63
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Effect of oral non-peptide GLP-1 receptor agonist orforglipron (LY3502970) in participants with obesity or overweight: A Phase 2 study
Diabetologie und Stoffwechsel 2024cited by 0position: middledoi
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
New England Journal of Medicine 2023cited by 409position: lastdoi
Examining the evidence for weight management in individuals with type 2 diabetes
Diabetes Obesity and Metabolism 2022cited by 16position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Deborah A. Robins · Eli Lilly (United States)2 papers (2023–2024)Christof Kazda · Eli Lilly (United States)2 papers (2023–2024)Edward Pratt · Eli Lilly (United States)2 papers (2023–2024)Lisa Connery · Alliance for Multispecialty Research (United States)2 papers (2023–2024)Thomas Blevins · Texas Diabetes & Endocrinology2 papers (2023–2024)Sohini Raha · Eli Lilly (United States)2 papers (2023–2024)Sean Wharton · Washington Center for Weight Management and Research2 papers (2023–2024)Axel Haupt · Eli Lilly (United States)2 papers (2023–2024)Julio Rosenstock · Dallas Diabetes Research Center2 papers (2023–2024)Kieren J. Mather · Eli Lilly (United States)2 papers (2023–2024)Julia P. Dunn · Eli Lilly (United States)1 papers (2022–2022)— · 1 papers (2022–2022)Rong Liu · Kunming University of Science and Technology1 papers (2023–2023)— · 1 papers (2022–2022)W. Timothy Garvey · University of California, Santa Cruz1 papers (2022–2022)Thomas Först · Johannes Gutenberg University Mainz1 papers (2024–2024)Xiaosu Ma · Eli Lilly (United States)1 papers (2023–2023)Guillermo E. Umpierrez · Emory University1 papers (2022–2022)— · 1 papers (2022–2022)